BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34995762)

  • 1. Mucous membrane pemphigoid.
    Du G; Patzelt S; van Beek N; Schmidt E
    Autoimmun Rev; 2022 Apr; 21(4):103036. PubMed ID: 34995762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
    Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
    Schmidt E; Rashid H; Marzano AV; Lamberts A; Di Zenzo G; Diercks GFH; Alberti-Violetti S; Barry RJ; Borradori L; Caproni M; Carey B; Carrozzo M; Cianchini G; Corrà A; Dikkers FG; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Rauz S; van Rhijn BD; Roth M; Setterfield J; Zillikens D; C Prost ; Zambruno G; Horváth B; Caux F
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1926-1948. PubMed ID: 34309078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
    Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
    Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1750-1764. PubMed ID: 34245180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
    Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
    Front Immunol; 2022; 13():903174. PubMed ID: 35720393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
    Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
    Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Endotypes Predict the Severity of Mucous Membrane Pemphigoid.
    Fairley JA; Crowe TP; Fakhimi M; Palmer SJ; Greiner MA; Hellstein JW; Van Daele DJ; Messingham KN
    J Invest Dermatol; 2023 Aug; 143(8):1479-1486.e3. PubMed ID: 36870557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies.
    Liu W; Li H; Jin Y; Cheng L; Shi L; Gao Y; Zhou Z; Feng S; Qian H; Hashimoto T; Li X
    Front Immunol; 2023; 14():1149119. PubMed ID: 36969205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity against laminin 332.
    Patzelt S; Schmidt E
    Front Immunol; 2023; 14():1250115. PubMed ID: 37638011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.
    Gaudin O; Seta V; Alexandre M; Bohelay G; Aucouturier F; Mignot-Grootenboer S; Ingen-Housz-Oro S; Bernardeschi C; Schneider P; Mellottee B; Caux F; Prost-Squarcioni C
    Front Immunol; 2018; 9():1030. PubMed ID: 29881377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase.
    Patzelt S; Pigors M; Steenbock H; Diel L; Boch K; Chakievska L; Künzel S; Busch H; Fähnrich A; Brinckmann J; Schmidt E
    Front Immunol; 2021; 12():812627. PubMed ID: 35197965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
    Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L
    Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid.
    Hofmann SC; Günther C; Böckle BC; Didona D; Ehrchen J; Gaskins M; Geerling G; Gläser R; Hadaschik E; Hampl M; Haßkamp P; Jackowski J; Kiritsi D; Nast A; Pleyer U; Reichel C; Roth M; Schumann M; Sticherling M; Worm M; Zillikens D; Goebeler M; Schmidt E
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1530-1550. PubMed ID: 36354061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.
    Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T
    Front Immunol; 2021; 12():771766. PubMed ID: 34899722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.
    Bekou V; Thoma-Uszynski S; Wendler O; Uter W; Schwietzke S; Hunziker T; Zouboulis CC; Schuler G; Sorokin L; Hertl M
    J Invest Dermatol; 2005 Apr; 124(4):732-40. PubMed ID: 15816831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid.
    van Beek N; Kridin K; Bühler E; Kochan AS; Ständer S; Ludwig RJ; Zillikens D; Schmidt E; Günther C
    JAMA Dermatol; 2022 Jan; 158(1):84-89. PubMed ID: 34817539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.
    Kamaguchi M; Iwata H
    Front Immunol; 2019; 10():34. PubMed ID: 30740099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.